← Back to Search

Diabetes Prevention Program Plus (DPP+) for Prediabetes (HH Trial)

N/A
Waitlist Available
Led By Crystal Clark Douglas, PhD
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women with prediabetes and eligible for the DPP, overweight/obesity, HTN (diagnosed or 3 successive high blood pressure readings), and history of excess gestational weight gain during most recent pregnancy
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12-months
Awards & highlights

HH Trial Summary

This trial is investigating whether the Diabetes Prevention Program, which is a lifestyle intervention program focused on healthy living, can also help prevent other chronic conditions like obesity and hypertension.

Eligible Conditions
  • Prediabetes
  • Pregnancy Weight Gain
  • High Blood Pressure
  • Obesity
  • Gestational Weight Gain

HH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

HH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Body mass index at 12 months
Change from Baseline Body mass index at 6 months
Diastolic blood pressure
+19 more
Secondary outcome measures
Change from Baseline C-reactive protein at 12 months
Change from Baseline C-reactive protein at 6 months
Change from Baseline Objective Total Weekly Physical activity minutes at 12 months
+9 more

HH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Diabetes Prevention Program Plus (DPP+)Experimental Treatment1 Intervention
CDC-approved 12-month DPP virtual lifestyle program expanded to include a CDC-approved module on hypertension prevention and treatment
Group II: Diabetes Prevention Program (DPP)Active Control1 Intervention
CDC-approved 12-month DPP virtual lifestyle program

Find a Location

Who is running the clinical trial?

The University of Texas Medical Branch, GalvestonLead Sponsor
241 Previous Clinical Trials
56,591 Total Patients Enrolled
Crystal Clark Douglas, PhDPrincipal InvestigatorUniversity of Texas

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment currently have any recruitment openings?

"According to clinicaltrials.gov, this experiment is still looking for participants - the initial post was made on October 15th 2022 and it has been altered as recently as August 26th 2022."

Answered by AI

What is the maximum capacity of participants for this clinical experiment?

"Affirmative. The research located on clinicaltrials.gov confirms that the investigation, initially posted in October of 2022, is currently seeking participants. Around 30 individuals are needed for this medical trial conducted at 1 site."

Answered by AI

Could I have the privilege of enrolling in this trial?

"To be eligible for this trial, the individuals must have experienced a certain degree of gestational weight gain and fall between 18 to 45 years old. This research is currently accepting approximately thirty participants."

Answered by AI

Is there an age limit on participants for this clinical trial?

"This medical trial is only open to those between 18 and 45 years of age. There are 128 studies available for participants below the age of majority, while 1007 can be found targeting older adults aged 65 or more."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
University of Texas Medical Branch
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Recent research and studies
clinicaltrials.govStudy
Healthy Hearts: Leveraging the Diabetes Prevention Program to Decrease Health Disparities in Women of Reproductive Age
2022. "Healthy Hearts: Leveraging the Diabetes Prevention Program to Decrease Health Disparities in Women of Reproductive Age". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05379296.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top